Sequencing and Analysis of the Hydra Genome
Chapman, Kirkness et al., Nature
An international research collaboration reports their sequencing and analysis of the Hydra magnipapillata genome, and compare it to the genomes of several other organisms. "The Hydra genome has been shaped by bursts of transposable element expansion, horizontal gene transfer, trans-splicing, and simplification of gene structure and gene content that parallel simplification of the Hydra life cycle," the authors write. They team suggests that comparisons of the Hydra genome to the reported sequences of other animals have helped them to elucidate the evolution of several of the organism's characteristics.
FDA Updates Warfarin Labeling with PGx-Guided Dosing Ranges
February 03, 2010
The FDA updated the labeling for warfarin on Jan. 22 to include PGx-guided dosing ranges. FDA's Lesko explained that the labeling provides dosing ranges in order to give doctors the flexibility to consider their patients clinical factors when determining the appropriate maintenance dose of the anticoagulant.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.
New to GenomeWeb? Register quickly here.
Related Stories
- NIH Launches Large Randomized Trial to Determine Utility of PGx-based Warfarin Dosing
February 18, 2009 / Pharmacogenomics Reporter - FDA Official Says Vectibix/Erbitux Relabeling May Guide Sponsors on Agency's Criteria for Accepting Retrospective Data
October 7, 2009 / Pharmacogenomics Reporter - GWAS Links CYP2C19 to Plavix Response; Randomized-Controlled Trial, PGx Consortium to Come
August 26, 2009 / Pharmacogenomics Reporter - UPDATE: Warfarin Genetic Testing Decreases Hospitalization Rate, Study Finds
March 16, 2010 / GenomeWeb Daily News - FDA Will Encourage Voluntary Reporting of LDT Adverse Events to MedWatch System
February 10, 2010 / Pharmacogenomics Reporter
